← Back to Foundations
Annual Giving
$500K
Grant Range
$10K – $5.0M

Tips for Applicants

Based on the available information, CERA appears to be primarily a research-conducting institution that receives funding and collaborates, rather than a grant-making foundation with open application programs for external entities. Potential partners should align with their strategic focus areas in eye diseases (glaucoma, inherited retinal diseases, macular degeneration, diabetic eye diseases) and emerging fields (ocular oncology, neurovascular biology, data science), and be prepared for collaborative research and innovation.

Giving Philosophy

CERA's giving philosophy is centered on achieving "impact through innovation" in eye research and patient care. They prioritize translational research, early identification and intervention for eye diseases, and the development and testing of novel therapies. "Partnering for impact" is key to their strategy, fostering collaborations with consumers, funders, industry, research and academic institutions, and clinical partners to accelerate discovery and implement transformative solutions.

ACNC Financial History

YearGrants GivenRevenueTotal AssetsNet Assets
FY2017
$3.9M
$4.9M$12.2M$12.2M
1yr total$3.9MSource: ACNC Annual Information Statements

Focus Areas

health
Geographic
AU-National
Recipients
community

Financial Details

Source of Wealth
As a corporate foundation and independent Medical Research Institute, CERA's revenue is derived from a diversified mix, including transformational philanthropy, commercial revenue streams such as clinical trials and commercialisation of new assets, and clinical services. No specific founder wealth is indicated.

Board & Leadership

Linked from structured person roles rather than unstructured foundation summary text.

Data Sources

Profile quality: low
Foundation profile updated: 26 April 2026 (52 days ago)
Website pages scraped: 5
Added: 27 February 2026 (110 days ago)
View on ACNC Register →